Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 1 , Pages 9-15 , January 2008

The Lowering of Vascular Atherosclerotic Risk (LOVAR) Program: An Approach to Modifying Cerebral, Cardiac, and Peripheral Vascular Disease

  • John E. Castaldo, MD

      Affiliations

    • Division of Neurology, Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania
    • Corresponding Author InformationAddress correspondence to John Castaldo, MD, Lehigh Valley Hospital, 17th and Chew Streets, Suite 403, PO Box 7017, Allentown, PA 18105-7017.
    • ,
  • James F. Reed III, PhD

      Affiliations

    • Division of Health Studies, Lehigh Valley Hospital, Allentown, Pennsylvania

Received 25 June 2007 ,Accepted 12 September 2007.

References 

  1. Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980–1990: The effects of secular trends in risk factors and treatment. JAMA. 1997;277:535–542
  2. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke and other cardiovascular disease in the United States: Findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102:3137–3147
  3. Satcher D. Cardiovascular disease trends and progress in the past 50 years: Lessons for our future. Abstracts from the 70th scientific sessions, American Heart Association, 1997(suppl);I-E.
  4. American Heart Association. Heart disease and stroke statistics–2006 update. Dallas: American Heart Association. Available at http://www.americanheart.org. Accessed 2007.
  5. Vogel RA. Risk factor intervention and coronary artery disease: Clinical strategies. Coron Artery Dis. 1995;6:466–471
  6. Ockene JK, McBride PE, Sallis JF, et al. Synthesis of lessons learned from cardiopulmonary preventive interventions in healthcare practice settings. Ann Epidemiol. 1997;7:s32–s45
  7. Pearson TA. An integrated approach to risk factor modification. In:  Topol EJ editors. Comprehensive cardiopulmonary medicine. Philadelphia: Lippincott-Raven; 1998;p. 297–331
  8. Mosca L, Arnett DK, Dracup K, et al. Task force on strategic research direction: Population/outcomes/epidemiology/social science subgroup key science topics report. Circulation. 2002;106:167
  9. Sheps S. The sixth joint national committee on the detection, evaluation and treatment of high blood pressure. Presented at the American Heart Association's cardiovascular health conference: Coming together for the 21st century, 1998 [abstract].
  10. Jones DW, Appel LJ, Sheps SG, et al. Measuring blood pressure accurately: New and persistent challenges. JAMA. 2003;289:1027–1030
  11. Chobanian A, Bakris G, George L, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA. 2003;289:2560–2571
  12. Troiano R, Glynn T. Treatment of nicotine dependence in children and youth. Presented at the American Heart Association's cardiovascular health conference: Coming together for the 21st century, 1998 [abstract].
  13. US Department of Health and Human Services . Healthy people 2010: Understanding and improving health. 2nd ed.. Washington (DC): US Government Printing Office; 2006;
  14. Lauer MS, Fontanarosa PB, Adult Treatment Panel III (ATP III) . Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: Executive summary of the third report of the national cholesterol education program (NCEP). JAMA. 2001;285:2486–2497
  15. Nicolucci A, Cavaliere D, Scorpiglione N, et al. DIS-AMD Italian Study Group A comprehensive assessment of the avoidability of long-term complications of diabetes. Diabetes Care. 1996;19:973–978
  16. Pearson T, Blair S, Daniels S, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update; consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106:388–391
  17. Smith S, Blair S, Bonow R. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic vascular disease: 2001 update; a statement for healthcare professionals from the AHA and the ACC. J Am Coll Cardiol. 2001;38:1581–1583
  18. Alderman M. Quantifying cardiovascular disease in hypertension. Hypertension. 1995;13:519–527
  19. Reed JF, Faust LA, Blanchard LW, et al. Behavioral health risks of Lehigh Valley adults, 1998: Measurable enhancement of the status of health initiative. Department of Community Health and Health Studies, Lehigh Valley Hospital, 1998.
  20. Pennsylvania Department of Health . Behavioral health risks of Pennsylvania adults. Harrisburg (PA): Bureau of Health Statistics; 2004;
  21. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 1990;336:129–133
  22. Concato J, Shah N, Horwitz R. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892
  23. Castaldo JE, Nester JM, Wasser T, et al. Physician attitudes regarding cardiovascular risk reduction: The gaps between clinical importance, knowledge and effectiveness. Dis Manage. 2005;8:93–105

 Supported by the Dorothy Rider Pool Health Care Trust.

PII: S1052-3057(07)00143-7

doi: 10.1016/j.jstrokecerebrovasdis.2007.09.002

Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 1 , Pages 9-15 , January 2008

Article Tools

* Image Usage & Resolution